Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 30,058
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12590143 | Antibodies binding to citrullinated histone 2A and/or 4 | 🖼🧊📄§ | 2026-03-31 | 2042-05-27 | 0 | 31 |
| 12590136 | Engineered T cells | 🖼🧊📄§ | 2026-03-31 | 2040-05-07 | 0 | 31 |
| 12589132 | CD80 extracellular domain Fc fusion proteins for treating PD-L1 negative tumors | 🖼🧊📄§ | 2026-03-31 | 2040-02-21 | 0 | 31 |
| 12590090 | Pyrimidine-and nitrogen-containing bicyclic compound | 🖼🧊📄§ | 2026-03-31 | 2040-09-30 | 0 | 31 |
| 12589104 | Thiosaccharides for use in treating coronavirus infection | 🖼🧊📄§ | 2026-03-31 | 2041-05-11 | 0 | 31 |
| 12590312 | NR4A super-repressors and methods of use thereof | 🖼🧊📄§ | 2026-03-31 | 2040-05-21 | 0 | 31 |
| 12590064 | Substituted benzamides for inhibiting perk activity | 🖼🧊📄§ | 2026-03-31 | 2043-04-13 | 0 | 31 |
| 12590070 | Adamantane derivatives as inhibitors of focal adhesion kinase | 🖼🧊📄§ | 2026-03-31 | 2040-12-02 | 0 | 31 |
| 12590092 | Antiviral agents and uses thereof | 🖼🧊📄§ | 2026-03-31 | 2042-01-28 | 0 | 31 |
| 12590098 | Pyrimido pyrimidinone compound and pharmaceutical composition comprising the same | 🖼🧊📄§ | 2026-03-31 | 2041-09-15 | 0 | 31 |
| 12590124 | Peptide with neutralizing activity against severe acute respiratory syndrome coronavirus 2 | 🖼🧊📄§ | 2026-03-31 | 2041-07-15 | 0 | 31 |
| 12590145 | Bi-specific chimeric antigen receptor | 🖼🧊📄§ | 2026-03-31 | 2041-05-18 | 0 | 31 |
| 12590141 | Monoclonal antibodies against Henipavirus glycoprotein G and encoding nucleic acids thereof | 🖼🧊📄§ | 2026-03-31 | 2041-06-27 | 0 | 31 |
| 12590146 | CLDN18.2-targeting antibody, preparation method therefor, and use thereof | 🖼🧊📄§ | 2026-03-31 | 2040-09-29 | 0 | 31 |
| 12590148 | Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy | 🖼🧊📄§ | 2026-03-31 | 2039-11-22 | 0 | 31 |
| 12590150 | Antibody against Nectin-4 and application thereof | 🖼🧊📄§ | 2026-03-31 | 2041-04-21 | 0 | 31 |
| 12590151 | Anti-human CD19 antibodies with high affinity | 🖼🧊📄§ | 2026-03-31 | 2042-11-03 | 0 | 31 |
| 12590159 | Compositions targeting epidermal growth factor receptor and methods for making and using the same | 🖼🧊📄§ | 2026-03-31 | 2045-02-25 | 0 | 31 |
| 12590156 | Fusion antibody for presenting antigen-derived T cell antigen epitope or peptide containing same on cell surface, and composition comprising same | 🖼🧊📄§ | 2026-03-31 | 2041-02-05 | 0 | 31 |
| 12590158 | Anti-trka antibody or antigen-binding fragment thereof, preparation method thereof, and application thereof | 🖼🧊📄§ | 2026-03-31 | 2042-02-23 | 0 | 31 |
| 12590161 | Anti-C-MPL antibody and use thereof | 🖼🧊📄§ | 2026-03-31 | 2041-11-09 | 0 | 31 |
| 12590166 | CD20 binding molecules and uses thereof | 🖼🧊📄§ | 2026-03-31 | 2041-07-16 | 0 | 31 |
| 12590165 | Methods and materials for identifying and treating membranous nephropathy based on elevated Semaphorin 3B | 🖼🧊📄§ | 2026-03-31 | 2041-03-05 | 0 | 31 |
| 12590163 | Agonistic anti-IL-2R antibodies and methods of use | 🖼🧊📄§ | 2026-03-31 | 2043-08-29 | 0 | 31 |
| 12590169 | 5T4 single domain antibodies and therapeutic compositions thereof | 🖼🧊📄§ | 2026-03-31 | 2039-10-09 | 0 | 31 |
| 12584116 | Attenuated variant of the rift valley fever virus, composition comprising same, and uses thereof | 🖼🧊📄§ | 2026-03-24 | 2041-06-03 | 0 | 31 |
| 12584120 | PCSK9 inhibitors and methods of use thereof | 🖼🧊📄§ | 2026-03-24 | 2043-01-25 | 0 | 31 |
| 12583895 | Polypeptides for restoring endothelial function and methods of use thereof | 🖼🧊📄§ | 2026-03-24 | 2040-02-12 | 0 | 31 |
| 12583892 | Conus-based toxin peptides, nucleic acids encoding same and uses thereof in modulating NMDA receptors | 🖼🧊📄§ | 2026-03-24 | 2042-06-28 | 0 | 31 |
| 12583888 | Bi-specific extracellular matrix binding peptides and methods of use thereof | 🖼🧊📄§ | 2026-03-24 | 2040-02-03 | 0 | 31 |
| 12583824 | 6-membered heteroarylaminosulfonamides for treating diseases and conditions mediated by deficient CFTR activity | 🖼🧊📄§ | 2026-03-24 | 2042-05-11 | 0 | 31 |
| 12583848 | Isoxazole-3-carboxamide derivatives and their use for treatment of diseases caused by virus infection | 🖼🧊📄§ | 2026-03-24 | 2040-09-25 | 0 | 31 |
| 12583854 | KRAS G12C inhibitors and methods of using the same | 🖼🧊📄§ | 2026-03-24 | 2041-09-22 | 0 | 31 |
| 12583857 | Anti-liferative agents comprising substituted benzo[e]pyrido[1,2-a][1,4]diazepines | 🖼🧊📄§ | 2026-03-24 | 2043-12-21 | 0 | 31 |
| 12583867 | Pyridone derivative crystal form and preparation method and application therefor | 🖼🧊📄§ | 2026-03-24 | 2039-11-05 | 0 | 31 |
| 12584105 | Autologous cell replacement therapy for Parkinson's disease | 🖼🧊📄§ | 2026-03-24 | 2040-05-21 | 0 | 31 |
| 12582599 | Methods for treatment of bladder cancer with gemcitabine | 🖼🧊📄§ | 2026-03-24 | 2042-07-07 | 0 | 31 |
| 12583919 | Antibodies that bind to LRP6 proteins and methods of use | 🖼🧊📄§ | 2026-03-24 | 2040-08-14 | 0 | 31 |
| 12583868 | JAK inhibitors and methods for synthesizing and using thereof | 🖼🧊📄§ | 2026-03-24 | 2043-03-13 | 0 | 31 |
| 12582702 | Methods for improving leptin sensitivity for the treatment of obesity and diabetes | 🖼🧊📄§ | 2026-03-24 | 2039-05-09 | 0 | 31 |
| 12582664 | Treatment of fragile x syndrome with cannabidiol | 🖼🧊📄§ | 2026-03-24 | 2042-10-20 | 0 | 31 |
| 12583906 | Actrii proteins and use in treating post-capillary pulmonary hypertension | 🖼🧊📄§ | 2026-03-24 | 2044-11-20 | 0 | 31 |
| 12583929 | Method of treating acute respiratory distress syndrome | 🖼🧊📄§ | 2026-03-24 | 2041-06-07 | 0 | 31 |
| 12584147 | Rational polyploid adeno-associated virus vectors for the treatment of disease | 🖼🧊📄§ | 2026-03-24 | 2043-05-19 | 0 | 31 |
| 12584179 | DNA methylation and mutational analysis methods for bladder cancer surveillance | 🖼🧊📄§ | 2026-03-24 | 2043-04-04 | 0 | 31 |
| 12584135 | Aptamers for personal health care applications | 🖼🧊📄§ | 2026-03-24 | 2042-12-14 | 0 | 31 |
| 12584137 | Aptamers for personal health care applications | 🖼🧊📄§ | 2026-03-24 | 2042-12-14 | 0 | 31 |
| 12584138 | Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies | 🖼🧊📄§ | 2026-03-24 | 2041-08-26 | 0 | 31 |
| 12583903 | Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof | 🖼🧊📄§ | 2026-03-24 | 2042-06-03 | 0 | 31 |
| 12583905 | Methods and compositions for dosing of allogeneic chimeric antigen receptor T cells | 🖼🧊📄§ | 2026-03-24 | 2044-11-20 | 0 | 31 |